March 20, 2021
Video
Naveen Pemmaraju, MD, discusses the results of combining ruxolitinib and navitoclax in different high-risk populations of relapsed/refractory myelofibrosis.
December 06, 2020
Video
Naveen Pemmaraju, MD, discusses the next steps for research in the field of myelofibrosis.
September 07, 2020
Video
Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.
June 17, 2020
Video
Naveen Pemmaraju, MD, discusses the clinical implications of a retrospective analysis of 26 patients with myelofibrosis who received benefit from ruxolitinib when it was rechallenged.